This Blanket Purchase Agreement (BPA) was awarded by the National Institutes of Health (NIH) Office of Logistics and Acquisition Operations to A&G Pharmaceutical, Inc. dba Precision Antibody, a for-profit manufacturer specializing in custom biological materials and research services. The single-award IDV has a ceiling value of $100,000,000 and a period of performance through January 31, 2026. Under this BPA, Precision Antibody will provide biological materials, laboratory and testing...
The Department of Health and Human Services, through the National Institute of Allergy and Infectious Diseases (NIAID), awarded a single-award Indefinite Delivery Contract valued at $146.3 million to the American Type Culture Collection (ATCC), a nonprofit organization, to provide a range of preclinical infectious disease models and specialized reagents. The contract aims to support the development, refinement, and utilization of animal and animal replacement models to evaluate candidate medical...
The Department of Health and Human Services National Institutes of Health has awarded a single-award blanket purchase agreement (BPA) to Government Scientific Source Inc., doing business as G S S, a leading distributor of laboratory products and equipment. The BPA, valued at $0 and with a last ordering date of March 30, 2025, provides a contractual vehicle for NIH's various institutes and centers to procure laboratory and medical supplies, water purification equipment, chemicals, biologicals,...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a single award indefinite delivery contract to American Type Culture Collection to provide preclinical services supporting the development of biopharmaceutical therapeutics and diagnostics for infectious diseases. With a potential value of $30 million and a period of performance from January 2023 through September 2030, the contract enables task orders to be issued across five areas: product...
This is a single-award Indefinite Delivery Contract (IDC) issued by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL), a contract research and manufacturing organization. The base contract has a potential value of $124,500,000 and a period of performance through September 28, 2028. The purpose is to provide NIAID Preclinical Development Support...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded an Indefinite Delivery Contract to PPD Development LP with a potential value of $545,452,906 to provide comprehensive and rapid response capabilities for research programs through September 2028. Task orders issued against the contract include over $132 million for clinical trial management support services relating to COVID-19, as well as orders valued at $2.33 million, $2 million, and $82.5...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute (NHLBI) awarded a $8,803,200.00 Delivery Order contract to Precision For Medicine, Inc., a for-profit organization, for a Biologic Specimen Repository. The contract is cost-plus-award-fee and runs from April 1, 2024 to March 31, 2029. Precision For Medicine, Inc. is an experienced provider of biorepository services, having previously supported repositories for the...
The U.S. Department of Health and Human Services (HHS) National Institutes of Health (NIH) has awarded a $99 million Indefinite Delivery Contract (IDC) for Laboratory Animal Procurement to Taconic Biosciences, Inc. This multiple award IDC enables NIH institutes, centers, and other federal health organizations to efficiently order a range of laboratory animals, including custom-engineered transgenic rodent models, to support their biomedical research objectives. Under this IDC, Taconic...
The provided information describes an Indefinite Delivery Contract (IDC) awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency of the U.S. government. The contract was awarded to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit manufacturer of goods specializing in biopharmaceutical research and development. The IDC, valued at a ceiling of $48,882,666, covers a broad range of pharmacology studies, animal model development, and...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded an Indefinite Delivery Contract to Lovelace Biomedical Research Institute on September 1, 2021 with a potential value of $545,452,906. Under the terms of the contract, Lovelace Biomedical Research Institute will provide a broad range of services to support biomedical research conducted by NIAID, including clinical trials, manufacturing and controls, nonclinical animal studies, analytics,...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences awarded a single-award Indefinite Delivery Contract to A&G Pharmaceutical, Inc., doing business as Precision Antibody, a for-profit manufacturer of goods. The contract, valued at a potential $696,028, aims to procure custom antibody development services in support of the agency's biomedical research initiatives. Through associated firm fixed price delivery orders, Precision Antibody will provide products such as monoclonal cell lines, monoclonal antibodies, labeled monoclonal antibodies, polyclonal antibodies, and drug-specific monoclonal antibodies against engineered proteins. These services will support research efforts in areas including Alzheimer's disease, malaria, COVID-19, oncology, and drug development at NIH component locations in Maryland. Precision Antibody has extensive experience providing similar antibody development services to HHS, including the National Cancer Institute and National Institute on Aging, through prior contract awards. The contract does not include any set-aside designations.